Document Detail

Obesity Treatment Using a Bioenterics Intragastric Balloon (BIB)-Preliminary Croatian Results.
MedLine Citation:
PMID:  20352525     Owner:  NLM     Status:  In-Data-Review    
AIM OF STUDY: This study aims to assess the effectiveness, tolerance, safety, and patient satisfaction of obesity treatments using the Bioenterics intragastric balloon (BIB).
METHODS: Prospective controlled trial of 33 obese patients who were treated with the BIB from March 2008 to March 2009 and who completed the 6 months treatment. Patients were selected on the basis of workup by a multidisciplinary team. The 33 obese patients (26 females, seven males) had a median age of 35 years (range 20-58). Their median baseline body weight (BW) was 114 kg (range 89-197) and their median body mass index (BMI) was 41.4 kg/m(2) (range 31.2-60.8).
RESULTS: Average weight reduction was 14 kg (range 2-37), loss total weight 10.1% (range 1.4-23.1), control BMI 35.6 kg/m(2) (range 29.4-50.3), delta BMI 4.5 (range 0.6-13.1), percentage excess weight loss 29.2 (range 2.8-53.6), and percent of excess BMI loss 29.3 (range 2.7-67.4). In one female patient the BIB was removed early due to intolerance. During the first week, minor side effects were noticed: nausea/vomiting occurred in 21 patients (63.6%), and abdominal cramps in 15 (45.5%). There was one balloon deflation and one impaction in the stomach. Those incidents were both successfully treated endoscopically. Patients had no major complications from mucosal lesions and no need for surgical interventions. All intragastric balloons were successfully removed endoscopically. Patients' treatment satisfaction correlated with the degree of BW loss (p = 0.0138).
CONCLUSION: BIB treatment in our setting showed the best results for individuals with BMI from 35 to 40 kg/m(2). Our preliminary results showed that BIB is safe, well tolerated with minor side effects, and alters quality of life for the better. The complication rate was negligible, due to the detailed pretreatment examinations and follow-up.
Marko Nikolic; Gorana Mirosevic; Neven Ljubicic; Marko Boban; Vladimir Supanc; Borka Pezo Nikolic; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Related Documents :
7617115 - Effects of body-weight loss and captopril treatment on proteinuria associated with obes...
16333555 - Endoscopic evaluation of the gastrojejunostomy in laparoscopic gastric bypass. a series...
11351155 - Is d2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
23664035 - Centerline is not as accurate as outer curvature length to estimate thoracic endograft ...
17403805 - The twenty to twenty-five-year outcomes of the harris design-2 matte-finished cemented ...
22044745 - Red blood cell transfusion and increased length of storage are not associated with deep...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obesity surgery     Volume:  21     ISSN:  1708-0428     ISO Abbreviation:  Obes Surg     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-08-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9106714     Medline TA:  Obes Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1305-10     Citation Subset:  IM    
Department of Internal Medicine, Gastroenterology and Hepatology Division, University Hospital "Sestre Milosrdnice", Vinogradska street 29, Zagreb, Croatia,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study.
Next Document:  Estrogen receptors in immunity and autoimmunity.